BON Announces Reciept of Nasdaq Compliance Letter
Rhea-AI Summary
Bon Natural Life (Nasdaq: BON), a bio-ingredient solutions provider for natural health and personal care industries, has received confirmation of compliance with Nasdaq's listing requirements. The company has successfully regained compliance with Listing Rule 5550(a)(2), known as the Bid Price Rule, as confirmed by the Nasdaq Hearings Panel on July 11, 2025.
Following this development, on July 29, 2025, Nasdaq officially closed the matter. However, BON will remain under a one-year Discretionary Panel Monitor to ensure continued compliance.
Positive
- Regained compliance with Nasdaq listing requirements
- Matter officially closed by Nasdaq
- Maintains Nasdaq listing status
Negative
- Company will be subject to one-year Discretionary Panel Monitor
News Market Reaction
On the day this news was published, BON declined 2.26%, reflecting a moderate negative market reaction. This price movement removed approximately $125K from the company's valuation, bringing the market cap to $5M at that time.
Data tracked by StockTitan Argus on the day of publication.
As previously reported on a Form 6-K filed with the
On July 29, 2025, the Company received notification from The Nasdaq Stock Market LLC confirming the Panel's decision and stating that the matter is now closed.
About Bon Natural Life Limited ("BON")
BON is a
For more information, please contact:
Cindy Liu | IR
Email: bonnatural@appchem.cn
Safe Harbor Statement
This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes,""expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/bon-announces-reciept-of-nasdaq-compliance-letter-302521595.html
SOURCE Bon Natural Life Limited